Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01124422Phase 4Completed
A Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01124422.